Tegretol in the Treatment of Diabetic Neuropathy

  • TD Wilton

Abstract

Patients suffering from peripheral neuropathy caused by diabetes mellitus were admitted to a double-blind trial comparing the efficacy of Tegretol (carbamazepine) and placebo. Objective and subjective parameters were measured to assess the effect of the treatment. Significant relief of pain was obtained, often within a few days, on a dosage of 200 mg Tegretol t.d.s. No interference with diabetic control was observed.

S. Afr. Med. J., 48, 869 (1974)

Author Biography

TD Wilton
Diabetic Clinic, Natalspruit Hospital, Alrode, Tvl
Published
2018-02-19
Section
Articles

Journal Identifiers


eISSN: 0256-95749
print ISSN: 2078-5135